Pittsboro, NC - Biolex Therapeutics, a company that uses its patented aquatic plant LEX system to make therapeutic proteins and monoclonal antibodies, has raised a $10 million round of financing according to a regulatory filing. (more…)

Research Triangle Park, NC – Viamet Pharmaceuticals Inc. has inked a licensing option agreement with the Novartis Option Fund that includes an upfront fee and potential milestone payments of more than $200 million in addition to product royalties. (more…)